DrugsControl Media Services

News Detail

US FDA offers guidance on development of antimicrobials for diabetic foot infections (19-10-2023)

Maryland, 18 Oct 2023: The US Food and Drug Administration (FDA) released new draft guidance on developing antimicrobial drugs specifically intended to treat diabetic foot infection, a focused area that is not included in the agency’s existing development guidance for drugs......
View Details

Source : Regulatory Focus
Diabetic foot infections (DFIs) US Food and Drug Administration (FDA) draft guidance

Related News